BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20592581)

  • 1. Novel missense mutation in charged multivesicular body protein 2B in a patient with frontotemporal dementia.
    Ferrari R; Kapogiannis D; Huey ED; Grafman J; Hardy J; Momeni P
    Alzheimer Dis Assoc Disord; 2010; 24(4):397-401. PubMed ID: 20592581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontotemporal dementia caused by CHMP2B mutations.
    Isaacs AM; Johannsen P; Holm I; Nielsen JE;
    Curr Alzheimer Res; 2011 May; 8(3):246-51. PubMed ID: 21222599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology.
    Clayton EL; Mizielinska S; Edgar JR; Nielsen TT; Marshall S; Norona FE; Robbins M; Damirji H; Holm IE; Johannsen P; Nielsen JE; Asante EA; Collinge J; ; Isaacs AM
    Acta Neuropathol; 2015 Oct; 130(4):511-23. PubMed ID: 26358247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel splice-site mutation in CHMP2B associated with frontotemporal dementia: The first report from China and literature review.
    Li C; Wen Y; Zhao M; Wang Y; Li P; Wang L; Wang S
    Mol Genet Genomic Med; 2023 Aug; 11(8):e2222. PubMed ID: 37272767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of CHMP2B
    Krasniak CS; Ahmad ST
    Brain Res; 2016 Oct; 1649(Pt B):151-157. PubMed ID: 26972529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations.
    Urwin H; Authier A; Nielsen JE; Metcalf D; Powell C; Froud K; Malcolm DS; Holm I; Johannsen P; Brown J; Fisher EM; van der Zee J; Bruyland M; ; Van Broeckhoven C; Collinge J; Brandner S; Futter C; Isaacs AM
    Hum Mol Genet; 2010 Jun; 19(11):2228-38. PubMed ID: 20223751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III.
    Jun MH; Han JH; Lee YK; Jang DJ; Kaang BK; Lee JA
    Mol Brain; 2015 Dec; 8():85. PubMed ID: 26651479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of microglial metabolism and inflammatory profile contributes to neurotoxicity in a hiPSC-derived microglia model of frontotemporal dementia 3.
    Haukedal H; Syshøj Lorenzen S; Winther Westi E; Corsi GI; Gadekar VP; McQuade A; Davtyan H; Doncheva NT; Schmid B; Chandrasekaran A; Seemann SE; Cirera S; Blurton-Jones M; Meyer M; Gorodkin J; Aldana BI; Freude K
    Brain Behav Immun; 2023 Oct; 113():353-373. PubMed ID: 37543250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHMP2B mutations are rare in French families with frontotemporal lobar degeneration.
    Ghanim M; Guillot-Noel L; Pasquier F; Jornea L; Deramecourt V; Dubois B; Le Ber I; Brice A;
    J Neurol; 2010 Dec; 257(12):2032-6. PubMed ID: 20625756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six generations of CHMP2B-mediated Frontotemporal Dementia: Clinical features, predictive testing, progression, and survival.
    Roos P; Johannsen P; Lindquist SG; Brown JM; Waldemar G; Duno M; Nielsen TT; Budtz-Jørgensen E; Gydesen S; Holm IE; Collinge J; Isaacs AM; ; Nielsen JE
    Acta Neurol Scand; 2022 May; 145(5):529-540. PubMed ID: 34997757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective activity of ursodeoxycholic acid in CHMP2B
    West RJH; Ugbode C; Fort-Aznar L; Sweeney ST
    Neurobiol Dis; 2020 Oct; 144():105047. PubMed ID: 32801000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Neurofilament Light in Patients with Frontotemporal Dementia Caused by CHMP2B Mutation.
    Toft A; Roos P; Jääskeläinen O; Musaeus CS; Henriksen EE; Johannsen P; Nielsen TT; Herukka SK; Hviid Simonsen A; Nielsen JE
    Dement Geriatr Cogn Disord; 2020; 49(6):533-538. PubMed ID: 33626531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS).
    Cox LE; Ferraiuolo L; Goodall EF; Heath PR; Higginbottom A; Mortiboys H; Hollinger HC; Hartley JA; Brockington A; Burness CE; Morrison KE; Wharton SB; Grierson AJ; Ince PG; Kirby J; Shaw PJ
    PLoS One; 2010 Mar; 5(3):e9872. PubMed ID: 20352044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A transgenic mouse expressing CHMP2Bintron5 mutant in neurons develops histological and behavioural features of amyotrophic lateral sclerosis and frontotemporal dementia.
    Vernay A; Therreau L; Blot B; Risson V; Dirrig-Grosch S; Waegaert R; Lequeu T; Sellal F; Schaeffer L; Sadoul R; Loeffler JP; René F
    Hum Mol Genet; 2016 Aug; 25(15):3341-3360. PubMed ID: 27329763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Genetics of Frontotemporal Dementia Elucidated by
    Vandal SE; Zheng X; Ahmad ST
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro.
    van der Zee J; Urwin H; Engelborghs S; Bruyland M; Vandenberghe R; Dermaut B; De Pooter T; Peeters K; Santens P; De Deyn PP; Fisher EM; Collinge J; Isaacs AM; Van Broeckhoven C
    Hum Mol Genet; 2008 Jan; 17(2):313-22. PubMed ID: 17956895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early microgliosis precedes neuronal loss and behavioural impairment in mice with a frontotemporal dementia-causing CHMP2B mutation.
    Clayton EL; Mancuso R; Nielsen TT; Mizielinska S; Holmes H; Powell N; Norona F; Larsen JO; Milioto C; Wilson KM; Lythgoe MF; Ourselin S; Nielsen JE; Johannsen P; Holm I; Collinge J; ; Oliver PL; Gomez-Nicola D; Isaacs AM
    Hum Mol Genet; 2017 Mar; 26(5):873-887. PubMed ID: 28093491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frontotemporal dementia: implications for understanding Alzheimer disease.
    Goedert M; Ghetti B; Spillantini MG
    Cold Spring Harb Perspect Med; 2012 Feb; 2(2):a006254. PubMed ID: 22355793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons learned from CHMP2B, implications for frontotemporal dementia and amyotrophic lateral sclerosis.
    Ugbode C; West RJH
    Neurobiol Dis; 2021 Jan; 147():105144. PubMed ID: 33144171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TMEM106B and ApoE polymorphisms in CHMP2B-mediated frontotemporal dementia (FTD-3).
    Rostgaard N; Roos P; Budtz-Jørgensen E; Johannsen P; Waldemar G; Nørremølle A; Lindquist SG; Gydesen S; Brown JM; Collinge J; Isaacs AM; ; Nielsen TT; Nielsen JE
    Neurobiol Aging; 2017 Nov; 59():221.e1-221.e7. PubMed ID: 28888721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.